Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
May 16, 2024 |
Director
Trans History: 2
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
May 15, 2024 |
Director
Trans History: 2
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
Feb 27, 2024 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Other acquisition or disposition (describe transaction) | 3,312 | -- | 183,380 |
Feb 20, 2024 |
EVP,General Counsel, Secretary
Trans History: 40
|
EVP,General Counsel, Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 58,870 | -- | 273,555 |
Feb 20, 2024 |
Chief Human Resources
Trans History: 16
|
Chief Human Resources | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 58,531 | -- | 303,442 |
Feb 20, 2024 |
EVP & Chief Financial Officer
Trans History: 153
|
EVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,800 | -- | 423,770 |
Feb 20, 2024 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,800 | -- | 244,071 |
Feb 20, 2024 |
Director, President & CEO
Trans History: 126
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 185,100 | -- | 988,804 |
Feb 20, 2024 |
Chief Innovation Officer
Trans History: 50
|
Chief Innovation Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,377 | -- | 305,605 |
Feb 20, 2024 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 59,377 | -- | 274,993 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.